Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: A randomized controlled trial

Hypertension

Volumn 65, Issue 4, 2015, Pages 736-742

  Muxfeldt, Elizabeth S ^a   Margallo, Victor ^a   Costa, Leonardo M S ^a   Guimarães, Gleison ^a   Cavalcante, Aline H ^a   Azevedo, João C M ^a   De Souza, Fabio ^a   Cardoso, Claudia R L ^a   Salles, Gil F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

continuous positive airway pressure; obstructive sleep apnea; randomized controlled trial; resistant hypertension to conventional therapy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NOCTURNAL BLOOD PRESSURE; OPEN STUDY; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSITIVE END EXPIRATORY PRESSURE VENTILATOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANT HYPERTENSION; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; COMPLICATION; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84929134218     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04852     Document Type: Article

References (30)

1. Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009; 5: 263-276
2. Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001; 163(3 pt 1): 685-689. doi: 10.1164/ajrccm.163.3.2005065
3. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005; 353: 2034-2041. doi: 10.1056/NEJMoa043104
4. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, Redline S, Resnick HE, Tong EK, Diener-West M, Shahar E. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010; 122: 352-360. doi: 10.1161/CIRCULATIONAHA.109.901801
5. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046-1053. doi: 10.1016/S0140-6736(05)71141-7
6. Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Levy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, McNicholas WT. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (Cooperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012; 30: 633-646. doi: 10.1097/HJH.0b013e328350e53b
7. Qaseem A, Holty JE, Owens DK, Dallas P, Starkey M, Shekelle P; for the Clinical Guidelines Committee of the American College of Physicians. Management of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013; 159: 471-483. doi: 10.7326/0003-4819-159-7-201310010-00704
8. Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med. 2012; 8: 587-596. doi: 10.5664/jcsm.2170
9. Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, Carrizo S, Mayos M, Barbé F; Spanish Sleep and Breathing Group. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ. 2010; 341: c5991. doi: 10.1136/bmj.c5991
10. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008; 51: 1403-1419. doi: 10.1161/HYPERTENSIONAHA.108.189141
11. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011; 57: 1076-1080. doi: 10.1161/HYPERTENSIONAHA.111.170308
12. Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008; 168: 2340-2346. doi: 10.1001/archinte.168.21.2340
13. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, De Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011; 58: 811-817. doi: 10.1161/HYPERTENSIONAHA.111.179788
14. Muxfeldt ES, Margallo VS, Guimarães GM, Salles GF. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014; 27: 1069-1078. doi: 10.1093/ajh/hpu023
15. Lozano L, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A, Espinel E, Ríos J, Untoria MD, Lloberes P. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens. 2010; 28: 2161-2168. doi: 10.1097/HJH.0b013e32833b9c63
16. Pedrosa RP, Drager LF, De Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest. 2013; 144: 1487-1494. doi: 10.1378/chest.13-0085
17. Martínez-García MA, Capote F, Campos-Rodríguez F, et al; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013; 310: 2407-2415. doi: 10.1001/jama.2013.281250
18. De Oliveira AC, Martinez D, Massierer D, Gus M, Gonçalves SC, Ghizzoni F, Steinhorst AM, Moreira LB, Fuchs SC, Fuchs FD. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial. Am J Respir Crit Care Med. 2014; 190: 345-347. doi: 10.1164/rccm.201403-0479LE
19. Dernaika TA, Kinasewitz GT, Tawk MM. Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med. 2009; 5: 103-107
20. Varounis C, Katsi V, Kallikazaros IE, Tousoulis D, Stefanadis C, Parissis J, Lekakis J, Siristatidis C, Manolis AJ, Makris T. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. Int J Cardiol. 2014; 175: 195-198. doi: 10.1016/j.ijcard.2014.04.240
21. Margallo VS, Muxfeldt ES, Guimarães GM, Salles GF. Diagnostic accuracy of the Berlin questionnaire in detecting obstructive sleep apnea in patients with resistant hypertension. J Hypertens. 2014; 32: 2030-2036; discussion 2037. doi: 10.1097/HJH.0000000000000297
22. Muxfeldt ES, De Souza F, Salles GF. Resistant hypertension: a practical clinical approach. J Hum Hypertens. 2013; 27: 657-662. doi: 10.1038/jhh.2013.34
23. Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA. 2014; 311: 2216-2224. doi: 10.1001/jama.2014.5180
24. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005; 46: 156-161. doi: 10.1161/01. HYP.0000170138.56903.7a
25. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension. 2007; 49: 1235-1241. doi: 10.1161/HYPERTENSIONAHA.107.087262
26. Muxfeldt ES, Cardoso CR, Salles GF. Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med. 2009; 169: 874-880. doi: 10.1001/archinternmed.2009.68
27. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest. 2005; 127: 2076-2084. doi: 10.1378/chest.127.6.2076
28. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, et al; Spanish Sleep And Breathing Network. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012; 307: 2161-2168. doi: 10.1001/jama.2012.4366
29. Schwartz SW, Cimino CR, Anderson WM. CPAP or placebo-effect?. Sleep. 2012; 35: 1585-1586. doi: 10.5665/sleep.2218
30. Hein H. Is sham CPAP a true placebo?. Am J Respir Crit Care Med. 2002; 165: 305. doi: 10.1164/ajrccm.165.2.correspondence.a.